(Q38327984)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22307227%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

title

Preclinical activity of LBH589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22307227%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22307227%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

José I Martín-Subero

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22307227%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

María J Blanco-Prieto

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22307227%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Paula Río

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22307227%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Jose A Martinez-Climent

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22307227%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

M J Calasanz

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22307227%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

A Vilas-Zornoza

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22307227%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

X Agirre

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22307227%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

G Abizanda

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22307227%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

C Moreno

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22307227%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

V Segura

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22307227%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

A De Martino Rodriguez

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22307227%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

E S José-Eneriz

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22307227%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

E Miranda

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22307227%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

L Garate

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22307227%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

J A García de Jalón

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22307227%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

J Rifón

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22307227%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

J C Cigudosa

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22307227%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

J Román-Gómez

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22307227%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

J M Ribera

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22307227%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

6 February 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22307227%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22307227%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22307227%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22307227%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

1517-1526

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22307227%20AND%20SRC:MED&resulttype=core&format=json

Acute lymphoblastic leukaemia

22 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

Concurrent intensive chemotherapy and imatinib before and after stem cell transplantation in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Final results of the CSTIBES02 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

Targeting FLT3 in primary MLL-gene-rearranged infant acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

21 January 2018

Epigenetics in cancer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

Epigenetics of acute lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

ASPP1, a common activator of TP53, is inactivated by aberrant methylation of its promoter in acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

Epigenetic regulation of microRNAs in acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

Aberrant DNA methylation and epigenetic inactivation of Eph receptor tyrosine kinases and ephrin ligands in acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

Epigenetic modifiers: basic understanding and clinical development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

Panobinostat (LBH589): a potent pan-deacetylase inhibitor with promising activity against hematologic and solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

Epigenetic down-regulation of BIM expression is associated with reduced optimal responses to imatinib treatment in chronic myeloid leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

In vitro and in vivo rationale for the triple combination of panobinostat (LBH589) and dexamethasone with either bortezomib or lenalidomide in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

Chromatin in need of a fix: phosphorylation of H2AX connects chromatin to DNA repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

The Notch/Hes1 pathway sustains NF-κB activation through CYLD repression in T cell leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

miR-449a and miR-449b are direct transcriptional targets of E2F1 and negatively regulate pRb-E2F1 activity through a feedback loop by targeting CDK6 and CDC25A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

E2F1-inducible microRNA 449a/b suppresses cell proliferation and promotes apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

MiR-320 and miR-494 affect cell cycles of primary murine bronchial epithelial cells exposed to benzo[a]pyrene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

Reversion of epigenetically mediated BIM silencing overcomes chemoresistance in Burkitt lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

Genome-wide identification of aberrantly methylated promoter associated CpG islands in acute lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

Histone deacetylase inhibitors profoundly decrease proliferation of human lymphoid cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

Demethylating agents in myeloid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

Successful induction therapy with decitabine in refractory childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

Novel treatment strategies for patients with relapsed classical Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

Pharmacologic suppression of MITF expression via HDAC inhibitors in the melanocyte lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

The potential role of histone deacetylase inhibitors in the treatment of non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

DNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

The histone deacetylase inhibitor LBH589 inhibits expression of mitotic genes causing G2/M arrest and cell death in head and neck squamous cell carcinoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

Mitochondrial Bax translocation partially mediates synergistic cytotoxicity between histone deacetylase inhibitors and proteasome inhibitors in glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

Effective targeting of quiescent chronic myelogenous leukemia stem cells by histone deacetylase inhibitors in combination with imatinib mesylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

Combined effects of novel tyrosine kinase inhibitor AMN107 and histone deacetylase inhibitor LBH589 against Bcr-Abl-expressing human leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

The novel histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph- acute lymphoblastic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

Inhibitors of deacetylases suppress oncogenic KIT signaling, acetylate HSP90, and induce apoptosis in gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

NFkappaB modulators in a model of glucocorticoid resistant, childhood acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

Potentiating effects of RAD001 (Everolimus) on vincristine therapy in childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

Characterization of childhood acute lymphoblastic leukemia xenograft models for the preclinical evaluation of new therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

The potential of histone deacetylase inhibitors for the treatment of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

7 January 2021

Partial uniparental disomy: a recurrent genetic mechanism alternative to chromosomal deletion in malignant lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

7 January 2021

Toward a total cure for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

7 January 2021

Histone deacetylase inhibitors have antitumor activity in two NOD/SCID mouse models of B-cell precursor childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.31

7 January 2021